Clinical Trial Update: Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessed the effectiveness and safety of insulin glargine in patients with Type 2 diabetes mellitus after failure of GLP-1 therapy; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine) (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED